GSA Capital Partners’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-182,826
| Closed | -$260K | – | 1995 |
|
|
2025
Q2 | $260K | Buy |
+182,826
| New | +$260K | 0.02% | 1353 |
|
|
2024
Q3 | – | Sell |
-76,429
| Closed | -$121K | – | 1915 |
|
|
2024
Q2 | $121K | Sell |
76,429
-146,859
| -66% | -$213K | 0.01% | 1514 |
|
|
2024
Q1 | $324K | Sell |
223,288
-348,175
| -61% | -$500K | 0.03% | 1171 |
|
|
2023
Q4 | $766K | Buy |
571,463
+236,674
| +71% | +$278K | 0.06% | 541 |
|
|
2023
Q3 | $475K | Buy |
+334,789
| New | +$474K | 0.04% | 831 |
|
|
2023
Q2 | – | Sell |
-272,705
| Closed | -$289K | – | 1843 |
|
|
2023
Q1 | $289K | Buy |
272,705
+24,760
| +10% | +$35.7K | 0.03% | 1048 |
|
|
2022
Q4 | $377K | Sell |
247,945
-113,604
| -31% | -$195K | 0.05% | 787 |
|
|
2022
Q3 | $766K | Sell |
361,549
-140,252
| -28% | -$296K | 0.1% | 288 |
|
|
2022
Q2 | $672K | Buy |
501,801
+171,963
| +52% | +$255K | 0.1% | 325 |
|
|
2022
Q1 | $696K | Buy |
329,838
+200,389
| +155% | +$488K | 0.09% | 343 |
|
|
2021
Q4 | $480K | Buy |
129,449
+98,103
| +313% | +$422K | 0.06% | 629 |
|
|
2021
Q3 | $156K | Buy |
+31,346
| New | +$180K | 0.02% | 1279 |
|
|
2021
Q1 | – | Sell |
-25,896
| Closed | -$264K | – | 1391 |
|
|
2020
Q4 | $264K | Sell |
25,896
-171,826
| -87% | -$1.11M | 0.04% | 815 |
|
|
2020
Q3 | $692K | Buy |
+197,722
| New | +$939K | 0.12% | 238 |
|
|
2020
Q2 | – | Sell |
-127,064
| Closed | -$432K | – | 999 |
|
|
2020
Q1 | $432K | Buy |
+127,064
| New | +$548K | 0.11% | 248 |
|
|
2019
Q4 | – | Sell |
-10,637
| Closed | -$61K | – | 1659 |
|
|
2019
Q3 | $61K | Buy |
+10,637
| New | +$72.3K | 0.01% | 1310 |
|
|
2019
Q1 | – | Sell |
-26,431
| Closed | -$173K | – | 1631 |
|
|
2018
Q4 | $173K | Buy |
+26,431
| New | +$296K | 0.02% | 1137 |
|
|
2017
Q4 | – | Sell |
-102,300
| Closed | -$1.95M | – | 1762 |
|
|
2017
Q3 | $1.95M | Buy |
+102,300
| New | +$2.11M | 0.13% | 163 |
|
|
2017
Q1 | – | Sell |
-9,643
| Closed | -$232K | – | 1937 |
|
|
2016
Q4 | $232K | Buy |
+9,643
| New | +$268K | 0.01% | 1501 |
|
|
2016
Q1 | – | Sell |
-21,563
| Closed | -$644K | – | 1863 |
|
|
2015
Q4 | $644K | Sell |
21,563
-54,519
| -72% | -$1.84M | 0.03% | 994 |
|
|
2015
Q3 | $2.4M | Buy |
76,082
+38,342
| +102% | +$1.87M | 0.12% | 192 |
|
|
2015
Q2 | $1.82M | Sell |
37,740
-21,481
| -36% | -$905K | 0.07% | 435 |
|
|
2015
Q1 | $2.57M | Buy |
59,221
+45,148
| +321% | +$1.62M | 0.1% | 217 |
|
|
2014
Q4 | $370K | Sell |
14,073
-1,099
| -7% | -$24.1K | 0.03% | 1131 |
|
|
2014
Q3 | $269K | Buy |
+15,172
| New | +$310K | 0.01% | 1335 |
|
Other funds holding PGEN
PCM
TCM
IAM
OCM
GSA Capital Partners's PGEN Position: Q3 2025 in Review
GSA Capital Partners sold out of Precigen (PGEN) in Q3 2025, closing a stake of 182,826 shares — an estimated $260K sold.
GSA Capital Partners first reported a position in PGEN in Q3 2014 and held it in 25 quarters. The position peaked at $2.57M in Q1 2015. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.
- GSA Capital Partners reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
- GSA Capital Partners sold 182,826 Precigen shares in Q3 2025, an estimated $260K.
- GSA Capital Partners first reported a position in Precigen in Q3 2014 and held it in 25 quarters.
- GSA Capital Partners's Precigen position peaked at $2.57M in Q1 2015.
- 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.
Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.